跳至主要内容
临床试验/NCT03055169
NCT03055169已完成不适用

TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure

University Hospital, Lille5 个研究点 分布在 1 个国家目标入组 994 人开始时间: 2012年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
994
试验地点
5
主要终点
value of the odds ratio associated with the relationship between a polymorphism TCF7L2 gene and the occurrence of hyperglycemia

研究概览

简要总结

This study evaluates the link between genetic polymorphisms as r7903146, rs12255372 of TCF7L2 gene and the risk of developing hyperglycemia during Intensive care unit stay

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • admission in ICU>48h
  • at least one organ dysfunction

排除标准

  • age< 18 years
  • pregnant women
  • admission less than 48h

结局指标

主要结局

value of the odds ratio associated with the relationship between a polymorphism TCF7L2 gene and the occurrence of hyperglycemia

时间窗: one year after inclusion

find a link between genetic polymorphism of TCF7L2 and the risk of developing hyperglycemia in intensive care patients with a least one organ dysfunction. the hyperglycemia is defined fasting glucose\> 1.26 g / l twice or need for treatment with insulin)

次要结局

  • Changes in inflammatory markers(one year after inclusion)
  • Insulin Resistance (HOMA)(one year after inclusion)
  • Changes in serum lipid profile(one year after inclusion)
  • Changes in liver enzymes(one year after inclusion)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验